{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:58:10Z","timestamp":1777417090868,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T00:00:00Z","timestamp":1311292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s11096-011-9544-8","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T12:32:51Z","timestamp":1311251571000},"page":"726-729","source":"Crossref","is-referenced-by-count":12,"title":["A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy"],"prefix":"10.1007","volume":"33","author":[{"given":"Nawin","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhat Kumar","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra Shekhar","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh Bihari","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,22]]},"reference":[{"key":"9544_CR1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/infdis\/154.6.1003","volume":"154","author":"R Badaro","year":"1986","unstructured":"Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, et al. New perspectives on a sub-clinical form of visceral leishmaniasis. J Infect Dis. 1986;154:1003\u201311.","journal-title":"J Infect Dis"},{"issue":"4","key":"9544_CR2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","volume":"31","author":"S Sundar","year":"2000","unstructured":"Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, et al. Failure of pentavalent antimony in visceral leishmaniasis in India. Clinical Infect Dis. 2000;31(4):1104\u20137.","journal-title":"Clinical Infect Dis"},{"key":"9544_CR3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4269\/ajtmh.1995.52.536","volume":"52","author":"TK Jha","year":"1995","unstructured":"Jha TK, Giri YN, Singh TK, Jha S. Use of amphotericin-B in drug- resistant cases of visceral leishmaniasis in north Bihar, India. Am J Trop Hyg. 1995;52:536\u20138.","journal-title":"Am J Trop Hyg"},{"issue":"25","key":"9544_CR4","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","volume":"356","author":"S Sundar","year":"2007","unstructured":"Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK. Injectable paromomycin for Visceral Leishmaniasis in India. New England J Med. 2007;356(25):2571\u201381.","journal-title":"New England J Med"},{"issue":"4","key":"9544_CR5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.01.001","volume":"25","author":"RC Jochim","year":"2009","unstructured":"Jochim RC, Teixeira C. Leishmania commandeers the host inflammatory response through neutrohils. Trends Parasitol. 2009;25(4):145\u20137.","journal-title":"Trends Parasitol"},{"issue":"2","key":"9544_CR6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","volume":"21","author":"J Alvar","year":"2008","unstructured":"Alvar J, Aparicio P, Aseffa A, Boer MD, Ca\u00f1avate C, Jean-Pierre Dedet, et al. The relationship between leishmaniasis and AIDS: the second 10\u00a0years. Clin Microbiol Rev. 2008;21(2):334\u201359.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"9544_CR7","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1086\/595710","volume":"48","author":"L Lachaud","year":"2009","unstructured":"Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum. Clin Infect Dis. 2009;48(2):e16\u201322.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"9544_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","volume":"30","author":"K Seifert","year":"2007","unstructured":"Seifert K, Perez-Victoria FJ, Stettler M, Sanchez-Canete MP, Castanys S, Gamarro F, et al. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistant that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. Int J Antimicrob Agents. 2007;30(3):229\u201335.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"9544_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trstmh.2010.10.008","volume":"105","author":"S Sundar","year":"2010","unstructured":"Sundar S, Sinha PK, Verma DK, Kumar N, Alam S, Pandey K, et al. Ambisome plus miltefosine for Indian patients with kala-azar. Trans R Soc Trop Med Hyg. 2010;105(2):115\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9764","key":"9544_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","volume":"377","author":"S Sundar","year":"2011","unstructured":"Sundar S, Sinha PK, Rai M, Verma DK, Kumar N, Alam S, et al. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet. 2011;377(9764):477\u201386.","journal-title":"Lancet"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-011-9544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-011-9544-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-011-9544-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T05:12:51Z","timestamp":1560402771000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-011-9544-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,22]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9544"],"URL":"https:\/\/doi.org\/10.1007\/s11096-011-9544-8","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,22]]}}}